🔎 Trials Near Me

Akèy › Limfòm selil B › Ohio › Columbus

Etid klinik pou Limfòm selil B nan Columbus, OH

7 etid pou Limfòm selil B ap chèche patisipan nan sit nan ak bò kote Columbus (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Ap rekriteFaz 3
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Ohio Health Research Institute, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06742996

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

Ap rekriteFaz 2
  • Ohio State University Medical Center Dept. of Internal Medicine, Division of Hematology, Columbus
Laj 60 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06052826

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Ap rekriteFaz 2
  • Research Site, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06526793

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Ap rekriteFaz 1/2
  • Research Site, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06564038

DALY II USA/ MB-CART2019.1 for DLBCL

Ap rekriteFaz 2
  • The Ohio State University Wexner Medical Center James Cancer, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma

Ap rekrite
  • Ohio State University Comprehensive Cancer Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT07609030

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • Nationwide Children's Hospital, Columbus
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Etid Limfòm selil B nan lòt vil

Lòt etid nan Columbus

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.